Dagmar Peters-Groth

Title: Dagmar Peters-Groth: Innovator in Pharmaceutical Chemistry

Introduction

Dagmar Peters-Groth is a prominent inventor based in Aachen, Germany. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative drug formulations. With a total of 3 patents to her name, her work has had a substantial impact on pain management therapies.

Latest Patents

Her latest patents focus on crystalline, anhydrous forms of oxymorphone hydrochloride. These patents disclose crystalline, anhydrous hydrochloride salts of 4,5α-epoxy-3,14-dihydroxy-17-methylmorphinan-6-one (oxymorphone) and report three polymorphic forms of these salts. The inventions further relate to methods for producing such salts and pharmaceutical compositions that comprise effective amounts of these salts as medicaments for the treatment and/or prevention of pain.

Career Highlights

Throughout her career, Dagmar has worked with notable companies in the pharmaceutical industry, including Endo Pharmaceuticals Inc. and Grünenthal GmbH. Her expertise in drug formulation and development has positioned her as a key player in her field.

Collaborations

Dagmar has collaborated with several professionals, including Andreas Fischer and Dagmar Lischke, enhancing her research and development efforts.

Conclusion

Dagmar Peters-Groth's innovative work in pharmaceutical chemistry continues to influence pain management therapies. Her contributions through her patents reflect her dedication to improving patient care and advancing medical science.